Rothschild & Co Downgrades Insulet to Neutral, Lowers Price Target to $220

Benzinga Newsdesk www.benzinga.com Negative 89.8%

Neg 89.8% Neu 0% Pos 0%

Rothschild & Co analyst Issie Kirby downgrades Insulet (NASDAQ:PODD) from Buy to Neutral and lowers the price target from $380 to $220.